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Abstract 
Objective: To perform chemical analysis and to evaluate the anti-biofilm and hemolytic effect of 
the essential oil of Cymbopogon citratus. Material and Methods: Gaseous chromatography 
coupled to mass spectrometer was performed for chemical characterization of the essential oil. To 
verify the antimicrobial action, the Minimum Inhibitory Concentration (MIC), Minimum 
Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC) were 
determined. From MIC, MBC and MFC data, concentrations were established to verify the anti-
biofilm effect and for the hemolysis test on human erythrocytes. A multispecies biofilm was 
developed in vitro and mouthwash applications were simulated to determine the inhibition of 
biofilm formation or its removal. Results were analyzed through ANOVA statistical test, 
complemented by the Tukey test, considering a significance level of 5%. Results: The major 
component of the essential oil is citral. MIC verified for Streptococcus mutans was 1mg / mL, while 
for Candida albicans, it was 125 µg/mL, presenting microbicidal effect for both microorganisms 
tested. The essential oil was able to inhibit biofilm formation (p<0.001), presenting non-toxic 
hemolysis percentage in concentration below 500 µg/mL. Conclusion: The essential oil of 
Cymbopogon citratus is antimicrobial, antibiofilm and non-toxic to human erythrocytes, 
representing a natural product with potential for use in Dentistry. 
 
Keywords: Plants, Medicinal; Biofilms; Cymbopogon; Drug Evaluation, Preclinical.
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Introduction 
Biofilm is a three-dimensional structure that forms on several solid surfaces considered as 
substrate [1]. It begins with the formation of an adsorbed film of exopolymers, constituting a 
mucilaginous matrix, which favors the adhesion of the first colonizing species, mostly aerobic 
microorganisms, increasing in thickness and complexity with maturation [1,2]. 
The more developed the biofilm, the greater its organization, as well as the number of 
microbial species and the interaction between them, being more difficult for the biofilm to be 
removed or disorganized [1,3]. Not all individuals are able to perform the biofilm control in the best 
way, or even some temporary or permanent conditions prevent proper oral hygiene by dental 
brushing, making it necessary the use of substances for the chemical control of biofilm [4,5]. 
One of the medicinal plants most cultivated and consumed in traditional medicine is 
Cymbopogon citratus, popularly known as lemon grass [6-9]. This plant has activities such as anti-
microbial, anti-inflammatory and anti-proliferative of tumor cells, which make it a potentially 
beneficial natural product for use in the health area [10,11]. 
However, each country has specific legislation to regulate and authorize research and 
marketing of plant-based products, whether medicines, cosmetics or foods [12]. In Brazil, regulation 
is carried out by the National Sanitary Surveillance Agency, which authorized the use of oral 
antiseptics manufactured with infusion of Lippia sidoides and the decoction of Siryphnoden drom 
adstrigens, with Cymbopogon citratus being indicated by this pharmacopoeia as a natural anxiolytic in 
the treatment of insomnia [13]. The European Union, through the Herbal Medicinal Products 
Committee (HMPC) standardizes indications, and Cymbopogon citratus has its indication through the 
Natural Sources of Flavorings compendium [14]. This procedure approximates the two regulations 
in countries under the jurisdiction of these agencies, valuing the popular knowledge and the local 
culture that already uses such products, requiring some tests to prove their safety less complex than 
for the production of new drugs of different origin [15]. 
For the development of new products for human health, research protocols should be 
followed to ensure clinical efficacy and safety. The research sequence for new drugs or therapeutic 
techniques follows a long and time-consuming path, starting from laboratory studies [16]. 
The aim of this work was to chemically characterize and to evaluate the antimicrobial and 
antibiofilm effects of the essential oil of Cymbopogon citratus, as well as to verify its toxicity and 
determine an ideal concentration for the development of a mouthwash solution formulated with its 
active pharmaceutical ingredient. 
 
Material and Methods 
The essential oil of Cymbopogon citratus was commercially obtained (Quinari Casa das 
Essências, Ponta Grossa, PR, Brazil), chemically analyzed and prepared for the determination of the 
Minimal Inhibitory Concentration (MIC) and the anti-adherent effect of biofilm at initial 
concentration of 2mg / mL. The MIC found was used as a parameter for the antibiofilm evaluation 
and hemolysis test. 
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Chemical Analysis 
Chemical characterization was performed by chromatography using a gas chromatograph 
coupled to mass spectrometer (GCMS-QP2010 SE, Shimadzu Corporation, Kyoto, Japan) and 
capillary column (J & W Scientific Inc., Folsom, California, USA) with stationary phase composed of 
5% phenyl and 95% dimethylpolysiloxane, measuring 30 m in length, 0.25 mm in internal diameter 
and 0.25 µm film thickness [17]. 
 
Minimum Inhibitory Concentration (MIC) Determination 
MIC determination was performed by serial microdilution technique, by placing 100 µL of 
culture medium in the wells of plates, on which 100 µL of EO (essential oil) were added and serially 
transferred from well to well to achieve the desired dilutions [18]. The test was completed by 
adding 100 µL of previously adjusted inoculum. 
Bacterial MIC was determined using BHI broth culture medium (Becton Dickinson GmbH, 
Heidelberg, Germany) for the growth of Streptococcus mutans UA159 and for fungal MIC using 
Sabouraud broth (Becton Dickinson GmbH, Heidelberg, Germany) for the development of Candida 
albicans ATCC 90029 strains. Assays were run in triplicate and plates were incubated at 37°C for 24 
hours. 
Controls of the strain viability were performed using medium only with inoculum, and 
positive using medium with inoculum and 0.12% chlorhexidine for bacteria and medium with 
inoculum and nystatin solution, for fungi. After that period, 50 µL of 1% TTC solution (2,3,5-
triphenyl tetrazolium chloride) were placed in the wells of plates, which were again incubated for 24 
hours at 37°C. 
To determine the Minimum Bactericidal Concentration, 50 µL were collected from wells 
corresponding to MIC, MICx2 and MICx4 and dripped onto petri dishes containing BHI agar 
medium (Becton Dickinson GmbH, Heidelberg, Germany), incubated for 24 hours at 37°C in 
microaerophilia. For determination of the Minimum Fungicidal Concentration, 50 µL were collected 
from wells corresponding to MIC, MICx2 and MICx4 and dripped onto petri dishes containing 
Sabouraud Dextrose agar medium (Becton Dickinson GmbH, Heidelberg, Germany), incubated in 
aerobiosis for 24 hours at 37°C. 
 
Anti-Biofilm Effect 
Streptococcus mutans UA159 and Candida albans ATCC 90029 standard strains were used to 
determine the antibiofilm effect, which were inoculated using BHI broth (Becton Dickinson GmbH, 
Heidelberg, Germany) in an equal portion of Sabouraud broth (Becton Dickinson GmbH, Heidelberg, 
Germany) and enriched with 5% sucrose. Plates were prepared according to the type of biofilm to be 
evaluated, with recent growth (initial biofilm) and late growth (mature biofilm). 
To simulate oral mouthwash applications, the concentrations defined by MIC, MICx2 and 
MICx4 and MICx8 were added to the wells of microdilution plates, remaining for 1 minute, followed 
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by washing and new addition of the culture medium and incubation. In the next step, plates were 
prepared for spectrophotometric reading (GloMax, Multi Detection System, Wisconsin, USA). 
In order to simulate mouthwash applications and to evaluate if the best action of the oil 
occurs in the inhibition of formation, biofilm removal or in both situations, the pre-defined times 
were adopted: 
G1 - Plates with Initial Biofilm Formation 
The strains were inoculated and incubated for 2 hours in microaerophilia at 37ºC, after the 
wells of plates were washed with 3 baths of 150 µL of neutral pH phosphate buffered saline (PBS). 
After 50 µl of each culture medium were added to wells and then 100 µl of EO and test 
concentrations and chlorhexidine were added, waiting 1 minute (simulating the mouthwash 
application). After one minute, the wells were again washed with 3 times with PBS and filled with 
equal parts of culture medium (50 µL of BHI broth and 50 µL of Sabouraud broth), proceeding with a 
new incubation of 12 hours. Process was repeated until 48 hours have elapsed. 
 
G2 - Plates with Formation of Mature Biofilm 
The strains inoculated and incubated for 48 hours in microearophilia at 37ºC. The contents 
liquid present in the wells of plates were removed and received 3 baths with 150 µL of PBS, after 
placed 50 µl of each culture medium were added to wells and then 100 µl of EO and test 
concentrations chlorhexidine were added, waiting 1 minute (simulating the mouthwash application). 
After one minute, again the wells washed 3 times with PBS and filled with equal parts of culture 
medium (50 µL of BHI broth and 50 µL of Sabouraud broth), proceeding with a new incubation of 12 
hours. Process repeated until 48 hours have elapsed. 
Control of the strain viability (medium with inoculum only) and positive control (medium 
with inoculum and 0.12% chlorhexidine) were performed. 
The preparation of plates for spectrophotometric reading respected the following protocol: 
after 48 hours of baths and incubations, plates were washed 2 times with 200 µl PBS and incubated 
again at 37°C for 45 minutes. Once dried, they received 110 µL of crystal violet solution (4%), 
waiting 45 minutes to stain the biofilm formed in the wells of plates. After the staining period, plates 
were washed 4 times with 200 µL distilled water and received 200 µL of 95% alcohol, waiting 
another 45 minutes. At the end of 45 minutes, 100 µl of contents present in the wells of plates were 
transferred to a new flat bottom plate and taken for reading on a plate reader (GloMax®-Multi 
Detection System, Wisconsin, USA) at wavelength 525 Nm. 
The biofilm inhibition / removal percentage can be calculated by the formula: 
% =    Absorbance found - negative control absorbance              x 100 
            positive control absorbance - negative control absorbance  
After percentages were defined, groups were classified according to the degree of biofilm 
inhibition / removal [19]: 0 =≤ 25% (non-inhibition); 1 = >25% to ≥ 50% (weak inhibition); 2 = 
>50% to ≥75% (moderate inhibition); 3 = >75% to ≥100% (strong inhibition). 
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Results were analyzed through descriptive and inferential statistics, in which the hypothesis 
of inhibition of biofilm formation or removal was tested using ANOVA statistical tests, 
complemented by the Tukey test, considering a significance level of 5% (p<0.05). 
 
Hemolytic Activity 
Human erythrocytes were used to determine cell selectivity of Cymbopogon citratus oil, with 
approval from the Ethics Research Committee of the State University of Paraíba, Brazil (Protocol 
No. 53237916.2.0000.5187). 
The cells were obtained from five healthy graduate dentistry students ranging in age from 
25 to 30 years, who had not used antibiotic and anti-inflammatory agents in the last 30 days. Blood 
was collected by the same operator with 10 mL disposable syringes, measuring 25x7 in the morning, 
without previous fasting. The collected blood was centrifuged at 1500 rpm for 15 minutes. 
Erythrocytes were isolated and washed in phosphate buffered saline (PBS) for three times and 
suspended at 2% in PBS. 
Erythrocytes suspensions were transferred to “U”-bottom microdilution plates and incubated 
1:1 with Cymbopgon citratus essential oil at concentrations previously defined in the Minimum 
Inhibitory Concentration (MIC, MICx2, MICx4 and MICx8) tests. The samples were diluted in 
distilled water (DW) or in PBS under product's natural pH (pH 4) or neutralized pH with NaOH. 
Distilled water and saline were used as positive and negative controls, respectively. 
After one hour of incubation, 70 µL of the supernatant were transferred to flat bottoms of 
microdilution plates and absorbance was measured (GloMax®-Multi Detection System, Wisconsin, 
USA). Hemolysis percentage was calculated by the formula [20]. 
%H =    sample absorbance - negative control absorbance                 x 100 
              positive control absorbance - negative control absorbance  
Hemolysis values up from 10% hemolysis was considered non-toxic to erythrocyte 
membrane, 10 to 49% are slightly toxic, 50 to 89% toxic, and 90 to 100% are highly toxic. 
 
Results 
Gas chromatography showed the presence of important phytochemicals in the essential oil of 
Cymbopogon citratus, all of the terpenes class, the majority being citral (Table 1). 
 
Table 1. Phytochemicals Identified By Cg/Ms. 
RT (min.) Area % Compound 
6.357 0.19  
7.398 0.59 Hept-5-en-2-one<6-methyl-> 
7.534 0.53 Myrcene 
14.316 0.49 Isogeranial 
15.115 0.84 Isogeranial 
17.784 43.48 2,6-octadienal,3,7-dimethyl-, (Z)- 
18.319 0.62 Geraniol 
19.121 53.27 Geranial 
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The data obtained in the antimicrobial evaluation allow defining the essential oil as 
antibacterial and antifungal, with bactericidal and fungicidal effect at concentrations determined as 
bacterial MIC of 1 mg / mL and fungal MIC of 125 µg / mL. 
In the anti-biofilm evaluation, EO had inhibitory effect on biofilm formation at the 
concentrations evaluated (p<0.05) (Table 2). 
 
Table 2. Determination of the anti-biofilm effect for G1. 
Group Test Absorbance (SD) p-value 
G1 CHX (µg/mL)  <0.0001 
50 0.099 (±0.010)a  
25 0.161 (±0.038)a  
12.5 0.117 (±0.022)a  
6.25 0.127 (±0.022)a  
G1 EO (µg/mL)  <0.0001 
1000 0.061 (±0.044)a  
500 0.108 (±0.021)a  
250 0.120 (±0.021)a  
125 0.177 (±0.050)a  
Negative Control 0.733 (±0.259)b  
Positive Control 0.240 (±0.174)a 0.0910 
SD = Standard deviation; *Different letters indicate statistically significant differences. 
 
However, there was no mature biofilm removing effect for the essential oil group, as 
observed in Table 3. 
 
Table 3. Determination of the anti-biofilm effect for G2. 
Group Test Absorbance (SD) p-value 
G2 CHX (µg/mL)  <0.0001 
50 0.279 (±0.110)b  
25 0.369 (±0.178)b  
12.5 0.874 (±0.089)b  
6.25 0.584 (±0.139)b  
G2 EO (µg/mL)  0.5559 
1000 0.993 (±0.022)a  
500 0.994 (±0.020)a  
250 1.007 (±0.010)a  
125 0.977 (±0.043)a  
Negative Control 0.976 (±0.020)a  
Positive Control 0.240 (±0.174)b <0.0001 
SD = Standard deviation; *Different letters indicate statistically significant differences. 
 
It is possible to define as "strong inhibition" the potential of inhibition of biofilm formation 
for EO, being as effective as chlorhexidine (Table 4). 
Table 5 shows the mean absorbance values and hemolysis percentages for the different EO 
manipulations. At low concentrations, both EO + S (saline) samples promoted hemolysis lower the 
negative control and both EO + DW (distilled water) sample revealed no-toxicity against 
erythrocyte membrane. 
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Table 4. Results of biofilm inhibition percentage for G2. 
Substance Test % 
EO (µg/mL) 
 
1000 89.9 
500 87.8 
250 86.6 
125 80.3 
CHX (µg/mL)  
50 89.2 
25 79.6 
12.5 88.4 
6.25 84.6 
 
Table 5 shows the mean absorbance values and hemolysis percentages for the different EO 
manipulations. At low concentrations, both EO + S (saline) samples promoted hemolysis lower the 
negative control and both EO + DW (distilled water) sample revealed no-toxicity against 
erythrocyte membrane. 
 
Table 5. Absorbance values and hemolysis percentages. 
Concentration 
(µg/mL) 
Absorbance 
EO pH 4 + S 
 
% 
Absorbance 
EO + S 
 
% 
Absorbance 
EO pH 4 + DW 
 
% 
Absorbance 
EO + DW 
 
% 
4000 0.194±0.033 87.3 0.184±0.068 81.6 0.178±0.037 78.3 0.211±0.037 97.8 
2000 0.121±0.029 44.1 0.151±0.046 62.2 0.116±0.020 41.5 0.172±0.056 74.7 
1000 0.049±0.001 2.01 0.080±0.025 19.8 0.061±0.012 8.9 0.081±0.017 20.8 
500 0.048±0.006 1.06 0.045±0.003 -0.8 0.055±0.013 5.5 0.052±0.012 3.4 
250 0.067±0.038 12.4 0.039±0.002 -3.9 0.067±0.023 12.5 0.056±0.015 5.6 
125 0.040±0.001 -3.7 0.036±0.004 -53.6 0.067±0.021 12.6 0.061±0.025 9.1 
 
Discussion 
The major component of the essential oil of Cymbopogon citratus is citral; an aldehyde formed 
by the geranial monoterpene in its cis and trans configurations. Other observed phytocompounds are 
myrcene and sulcatone, aromatic compounds that may contribute to the strong odor present in the 
EO. The findings corroborate literature regarding the chemical composition of the product, and 
quantities are variable regardless of phytocompound [21,22]. These variations may be related to 
differences in the period and site of collection of plants for the essential oil production [13]. 
The essential oil of Cymbopogon citratus demonstrated microbicidal effect on S. mutans and C. 
albicans, and no Colony Forming Unit was observed in Petri dishes used for MFC and MBC 
determination. The results obtained for MICs with EO can be considered very good [23], since they 
are at concentrations below 1mg / mL. Some authors consider substance with MIC less than 500 µg 
/ mL as potent [24]. However, the effect on yeasts observed in this study can be considered 
moderate [25], since MIC was 125 µg / mL, being between 100 and 500 µg / mL, whereas the 
antibacterial effect was weak, with MIC of 1mg / mL. A previous study using dye formulation with 
C. citratus found no antibacterial effect [26]. 
 Pesqui. Bras. Odontopediatria Clín. Integr. 2019; 19(1):e5011 
 
8 
Several authors corroborate the results described here for the antibacterial effect of the 
essential oil of Cymbopogon citrates [6], and it has been demonstrated that this substance may act as 
an enhancer of the antimicrobial effect of some antibiotics [27]. Interaction between Streptococcus 
mutans and Candida albicans has been reported in literature as increasing the adherence of the species 
to biofilm [28,29]. For this reason, the multispecies biofilm developed in the present study used 
these microorganisms as microbial association. 
The present study observed antimicrobial effect of the essential oil of Cymbopogon citratus; 
however, the fungicide action occurred in a much lower concentration when compared to the 
bactericidal concentration. This may be due to the mechanism of action of the phytotherapeutic 
product, not fully elucidated, which provides toxicity to yeast cells more intensely than to bacterial 
cells studied here. Possibly, this phytotherapic has good microbicidal effects by the action of terpenes 
(citral in greater amount) present in it [27]. 
It is known that the use of mouthwash will occur mostly on epithelial cells of the oral 
mucosa. However, it is important to know the possibility of substance penetration into tissues and 
the toxic effects of the product. Since erythrocytes are cells of simple composition, in which it is 
possible to measure the action of drugs on the cell membrane [20], we opted for the initial 
investigation of the toxic potential of this phytomedicine on human erythrocytes. 
Monoterpenes are capable of changing the fluidity of the cell membrane of erythrocytes and 
fibroblasts and, consequently, favor the penetration of substances inside the cells. However, 
depending on concentration and interactions with membrane receptors, it is not capable of causing 
cell damage [30-33]. This may justify the protective effect observed in the hemolysis test with the 
manipulation of the essential oil in saline solution and neutralized pH at concentrations below 500 
µg / mL. The results suggest a change in the organization of the erythrocyte membrane, preventing 
the loss or gain of content to the medium, favoring the maintenance of the intact cell. 
 
Conclusion 
The essential oil of Cymbopogon citratus demonstrated antimicrobial effect on Streptococcus 
mutans and Candida albicans, and was able to inhibit the in vitro formation of multispecies biofilms, 
presenting low toxicity on the cell membrane of erythrocytes at concentrations lower than 500µg / 
mL. 
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